1060 / 1456
Assessed impact on OAR
doses not target dose
Contoured OARs on CBCTs and recalc’d
with correction for HU differences
Where did this
weight loss
occur?
Weight loss and parotid shrinking did occur,
but insignificant impact on OAR doses
Results inconsistent with previous studies
Impact of neoadjuvant therapy?
Demonstrates the benefit of 3D imaging
Discusses options of dose calculation from CBCT